HERPESVIRUSES AS ONCOLYTIC AGENTS
The following sections are included:
Oncolytic Virotherapy — Background
The Viruses Under Clinical Experimentation and the Targeted Tumors
Strategies to Improve the Currently Available Oncolytic HSVs
The Path to Highly Tumor-Specific Oncolytic HSVs. Retargeting to Tumor Specific Receptors
Concluding Remarks
References